Clinical Trials, Research and Development
September 20, 2022
Via: GENImpaired immunity and recurring infections are common in type 1 and type 2 diabetes. Studies by researchers at Karolinska Institute, have now shown that the immune system of individuals with diabetes displays reduced levels of the antimicrobial peptide (AMP) psoriasin, […]
July 19, 2024
July 11, 2024
July 11, 2024